Newsfilter article unlocker

Enter Newsfilter article ID in the field below.
Example: https://newsfilter.io/articles/39be1bef03e66cdc886c08a2a6319c47

Henry Schein (HSIC.O) on Tuesday reaffirmed its annual forecast after beating Wall Street expectations for first-quarter profit as the medical supplies distributor saw ​strong demand across its dental business.

The U.S. dental ‌market has seen instability marked by uneven patient visits and weakening demand for higher-cost procedures, which analysts expect to stabilize in 2026.

"I ​am pleased with our strong first quarter results ​that reflect continuing momentum from the second half of ⁠last year as we grow market share and expand ​gross margins," Henry Schein CEO Fred Lowery said, adding that the ​company remains confident it can deliver on its 2026 targets.

Henry Schein reaffirmed its 2026 adjusted profit forecast of $5.23 to $5.37 per share. Analysts estimate the ​company's annual profit at $5.32 per share, according to data compiled by LSEG.

The ​company also reiterated expected sales growth of about 3% to 5% for ‌the ⁠year.

Henry Schein reaffirming its annual forecast is "unsurprising given a backdrop of macro uncertainty," Leerink Partners analyst Michael Cherny said in a note.

In the first quarter, Henry Schein's largest segment, ​Global Distribution and ​Value‑Added Services, ⁠reported revenue growth of 6.1% at $2.84 billion.

Revenue from its Global Specialty Products segment, which includes dental implants and ​biomaterials, rose 8.1% to $397 million, while Global Technology ​sales, ⁠which include practice‑management software and digital services, increased 7% to $173 million.

Henry Schein reported adjusted earnings of $1.32 per share, up from $1.15 ⁠a ​year earlier and above analysts’ estimates ​of $1.22, according to data compiled by LSEG.

Revenue rose 6.3% to $3.4 billion, compared with the ​average of analysts’ estimates of $3.34 billion.